Olle Ringd n

RESULTS OF DIFFERENT STRATEGIES FOR REDUCING CYTOMEGALOVIRUS-ASSOCIATED MORTALITY IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS1

Per Ljungman, J Aschan, Ilona Lewensohn‐Fuchs et al. · Transplantation · 1998 · 177 citations

LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1

Olle Ringd n, Mats Remberger, Stefan Carlens et al. · Transplantation · 1998 · 70 citations

TREATMENT OF HEPATIC VENOOCCLUSIVE DISEASE WITH RECOMBINANT HUMAN TISSUE PLAMINOGEN ACTIVATOR OR ORTHOTOPIC LIVER TRANSPLANTATION AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION1

Hans H gglund, Olle Ringd n, Bo‐Göran Ericzon et al. · Transplantation · 1996 · 46 citations

Solid Organ Transplantation, Pathology, Rt-pa Therapy +19

Five-Year Follow-Up of Two Siblings with Aspartylglucosaminuria Undergoing Allogeneic Stem-Cell Transplantation from Unrelated Donors

Gunilla Malm, Jan-Eric M nsson, Jacek Winiarski et al. · Transplantation · 2004 · 31 citations

TRANSPLANTATION OF AUTOLOGOUS AND ALLOGENEIC BONE MARROW WITH LIVER FROM A CADAVERIC DONOR FOR PRIMARY LIVER CANCER1

Olle Ringd n, Gunnar S derdahl, Jonas Mattsson et al. · Transplantation · 2000 · 30 citations